The NeXT Dx test utilizes DNA isolated from a patient’s tumor tissue and matched normal tissue to perform whole exome analysis and RNA isolated from a patient’s tumor tissue to perform transcriptome analysis. The clinical report includes SNVs, indels, CNAs, MSI and TMB results derived from DNA analysis and fusion results derived from RNA analysis.